Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNetAnna Collado Gimbert, María del Mar Mañú‐Pereira, Ana M. Ortuño et al.|HemaSphere|2023Cited by 11
Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Results in Reduced Hepatocellular Inflammation and Improved Liver Function in Patients with Transfusion-Dependent Anemia.Pierre Brissot, D. Alberti, Bruno Turlin et al.|Blood|2005Cited by 10
P1478: INTEGRATIVE DIAGNOSIS OF SICKLE CELL DISEASE PATIENTS FOR PERSONALIZED MEDICINEAmira Idrizovic, M. D. M. Mañú Pereira, Anna Collado Gimbert et al.|HemaSphere|2022Cited by 0